CLASS I ONGOING Drug recall · Reported 8 Jul 2026 · FDA Enforcement Report

Revitaderm Wound Care Gel, Benzalkonium Chloride recalled by Blaine Labs

Blaine Labs is recalling Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, distributed nationwide in the US. The recall was initiated on 8 Apr 2026 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot#: BL3608, Exp. 07/01/28.
Quantity recalled1,171 - 1 oz bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0692-2026
FDA event ID
98731
Recalling firm
Blaine Labs, Santa Fe Springs, CA
Classification
Class I
Status
Ongoing
Recall initiated
8 Apr 2026
FDA classified
16 Jul 2026
Reported
8 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Sterility

Timeline

8 Apr 2026Recall initiated by company
8 Jul 2026Published in enforcement report+91 days
16 Jul 2026Classified by FDA+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670, NDC 63347-120-02.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

Which lots are affected?

Lot#: BL3608, Exp. 07/01/28.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

7 other products · FDA event 98731

This product is part of a recall event; the main page for the event is Terpenicol Antifungal Solution, (Undecylenic recalled by Blaine Labs.

More recalls from Blaine Labs

All 9